Suruga Clinic

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Obesity3 trials
• Type 2 diabetes2 trials
• Diabetic neuropathy1 trial
• Type 1 diabetes1 trial

Phase

• Phase 33 trials
• Phase 21 trial

Status

• Active, not recruiting2 trials
• Completed1 trial
• Recruiting1 trial

Lead sponsor

• Amgen2 trials
• Eli Lilly and Company2 trials

Running trials

• Recruiting

  Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

  NCT07684144· Phase 3· Amgen· Source

• Active, not recruiting

  A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight

  NCT06914895· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

  NCT06858878· Phase 3· Amgen· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Completed

  A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain

  NCT06074562· Phase 2· Eli Lilly and Company· Source